Patents by Inventor Meggan Czapiga

Meggan Czapiga has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MOLECULAR ASSESSMENT OF TRBC USAGE
    Publication number: 20220010377
    Abstract: The invention relates to a method of determining the T cell receptor ? chain (TRBC) gene type of a cell, the method comprising (a) determining the J gene type expressed in said cell, and (b) inferring from (a) the TRBC gene type expressed in said cell. The invention further relates to use of a CAR T cell targeted to a T cell receptor ? chain (TRBC) type 1, or a CAR T cell targeted to a T cell receptor ? chain (TRBC) type 2. The invention further relates to a method of medical treatment, and to nucleic acid probes.
    Type: Application
    Filed: July 18, 2019
    Publication date: January 13, 2022
    Inventors: Shimobi Onuoha, Meggan Czapiga, Biao Ma
  • RNase a peptides, fragments and uses thereof
    Patent number: 8748572
    Abstract: The present invention features isolated polypeptides that have bactericidal and angiogenic activities. The invention features isolated polypeptides comprising amino acid sequences of RNase A ribonucleases, fragments and variants thereof, pharmaceutical compositions, and methods for treatment of a subject.
    Type: Grant
    Filed: August 24, 2007
    Date of Patent: June 10, 2014
    Assignee: The United States of America, as represented by the Secretary, Department of Health & Human Services
    Inventors: Takeaki Nitto, Kimberly D. Dyer, Meggan Czapiga, Helene F. Rosenberg, Steven J. Siegel
  • RNASE A PEPTIDES, FRAGMENTS AND USES THEREOF
    Publication number: 20100305025
    Abstract: The present invention features isolated polypeptides that have bactericidal and angiogenic activities. The invention features isolated polypeptides comprising amino acid sequences of RNase A ribonucleases, fragments and variants thereof, pharmaceutical compositions, and methods for treatment of a subject.
    Type: Application
    Filed: August 24, 2007
    Publication date: December 2, 2010
    Applicant: Government of the US, as represented by the Secretary, Department of Health and Human Services
    Inventors: Takeaki Nitto, Kimberly D. Dyer, Meggan Czapiga, Helene F. Rosenberg, Steven J. Siegel
  • N-formyl peptide receptor mediation of platelet chemotaxis toward injured cells and activation of immune response
    Publication number: 20060171944
    Abstract: The present invention relates to N-formyl peptides that induce an immune response, specifically, stimulating mobilization of platelets to a site of injury, thereby healing wounds. Further, the invention relates to N-formyl peptide receptor inhibitors, specifically N-formyl peptide receptor antibodies, that inhibit an immune response, thereby blocking inflammation and the mobilization of platelets and other phagocytic cells to a site of injury.
    Type: Application
    Filed: October 4, 2002
    Publication date: August 3, 2006
    Inventors: Julie Lekstrom-Himes, Allan Kirk, Meggan Czapiga, David Kleiner